Chemotherapy and immunotherapy: A close interplay to fight cancer?

被引：17
作者：
Hanoteau, Aurelie [1 ]
Moser, Muriel [1 ]
机构：
[1] Univ Libre Bruxelles, Dept Mol Biol, Immunobiol Lab, Brussels, Belgium
来源：
ONCOIMMUNOLOGY | 2016年 / 5卷 / 07期
关键词：
Chemotherapy; drug efflux; homeostasis; immunotherapy; IL-7/IL-15; lymphopenia; memory T cells; T-CELL HOMEOSTASIS; ANTITUMOR IMMUNE-RESPONSE; CD4(+) CELLS; IN-VIVO; MEMORY; PROLIFERATION; INTERLEUKIN-7; IL-7; NAIVE; THERAPY;
D O I：
10.1080/2162402X.2016.1190061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In theory, the immunotherapy of cancer should induce the selective destruction of cancer cells and a long-term specific protection, based on the specificity and memory of immunity. This contrasts with the collateral damages of conventional therapies and their toxic effects on host tissues. However, recent data suggest that chemotherapy may potentiate ongoing immune responses, through homeostatic mechanisms. Massive tumor death, empty "immune" niches and selected cytokines may act as a danger signal, alerting the immune system and amplifying pre-existing antitumor reactivity.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
    Tianqian Zhang
    Dorothee Herlyn
    Cancer Immunology, Immunotherapy, 2009, 58 : 475 - 492
  • [22] Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
    Zhang, Tianqian
    Herlyn, Dorothee
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (04) : 475 - 492
  • [23] Excellent response to chemotherapy post immunotherapy
    Dwary, Ashish D.
    Master, Samip
    Patel, Abhishek
    Cole, Constance
    Mansour, Richard
    Mills, Glenn
    Koshy, Nebu
    Peddi, Prakash
    Burton, Gary
    Hammoud, Dalia
    Beedupalli, Kavitha
    ONCOTARGET, 2017, 8 (53) : 91795 - 91802
  • [24] Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
    Garcia-Dominguez, Daniel J.
    Lopez-Enriquez, Soledad
    Alba, Gonzalo
    Garnacho, Carmen
    Jimenez-Cortegana, Carlos
    Flores-Campos, Rocio
    de la Cruz-merino, Luis
    Hajji, Nabil
    Sanchez-Margalet, Victor
    Hontecillas-Prieto, Lourdes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [25] CHEMOTHERAPY AND IMMUNOTHERAPY OF COLORECTAL-CANCER
    MASUCCI, G
    RAGNHAMMAR, P
    FRODIN, JE
    HJELM, AL
    WERSALL, P
    FAGERBERG, J
    OSTERBORG, A
    MELLSTEDT, H
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1991, 8 (03): : 207 - 220
  • [26] Metronomic chemotherapy and immunotherapy in cancer treatment
    Chen, Yu-Li
    Chang, Ming-Cheng
    Cheng, Wen-Fang
    CANCER LETTERS, 2017, 400 : 282 - 292
  • [27] Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
    Hamid, Marwa Abdel
    Pammer, Lorenz M.
    Lentner, Theresa K.
    Doleschal, Bernhard
    Gruber, Rebecca
    Kocher, Florian
    Gasser, Elisabeth
    Joebstl, Anna
    Seeber, Andreas
    Amann, Arno
    CURRENT ONCOLOGY REPORTS, 2024, 26 (10) : 1258 - 1270
  • [28] Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
    Zhang, Lei
    She, Risheng
    Zhu, Jianlin
    Lu, Jin
    Gao, Yuan
    Song, Wenhua
    Cai, Songwang
    Wang, Lu
    BMC CANCER, 2022, 22 (01)
  • [29] Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy
    Yu, Wei-Di
    Sun, Guan
    Li, Jun
    Xu, Jiang
    Wang, Xiaochen
    CANCER LETTERS, 2019, 452 : 66 - 70
  • [30] Patient expectations are better for immunotherapy than traditional chemotherapy for cancer
    Andreas Ihrig
    Jenniffer Richter
    Carsten Grüllich
    Leonidas Apostolidis
    Peter Horak
    Matthias Villalobos
    Miriam Grapp
    Hans-Christoph Friederich
    Imad Maatouk
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 3189 - 3198
12345